Ontology highlight
ABSTRACT:
SUBMITTER: Recine F
PROVIDER: S-EPMC5328291 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
OncoTargets and therapy 20170223
Soft tissue sarcomas (STS) represent a variety of tumors of mesenchymal origin, accounting for about 1% of all adult cancers. This group of tumors comprises over 60 different histotypes with different biology showing different sensitivity to therapeutic agents. For decades, the standard first-line systemic treatment of metastatic STS has comprised anthracycline based-chemotherapy. Second-line therapy options include agents such as ifosfamide, gemcitabine, and pazopanib, but the optimal sequentia ...[more]